Environment

A01

Gut microbiome metabolites in MS inflammation and neurodegeneration

Univ.-Prof. Dr. med. Aiden Haghikia
Universitätsklinik für Neurologie
Magdeburg

Univ.-Prof. Dr. med. Ralf Gold
Universitätsklinik für Neurologie
Bochum

 

A08

Impact of diet and intestinal microbiota on the gut-CNS axis – implication for CNS autoimmunity

Univ.-Prof. Dr. med. Luisa Klotz
Klinik für Neurologie mir Institut für Translationale Neurologie
Münster

Prof. Dr. med. Dr.rer.nat. Detlef Schuppan
Institut für Translationale Immunologie, Forschungszentrum Immuntherapie
Mainz

 

A10

Skin-sensing of environmental factors and their impact on the development of multiple sclerosis

Univ.-Prof. Dr. med. Karin Loser
Zentrum für Experimentelle Dermatologie und Immunbiologie der Haut
Oldenburg

Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

News

Fri, 29/10/2021
Seminar on DFG’s equal opportunities measures
On 7 December 2021 and 16 February 2022, the DFG will offer an online information event for researchers and science managers who would like to gain an overview of the DFG’s equal opportunities measures in the various funding procedures. Date I: 7 December 2021, 1:00 – 2:30 p.m. Direct link to Webex: https://dfg.webex.com Date II: […]...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more